GAVI board approves $775 million for Covid-19 vaccine delivery - statement
The COVAX facility, run jointly with the World Health Organization, has delivered 90 million doses to 132 countries since February
A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
The board of the GAVI vaccine alliance has approved $775 million to fund the delivery of Covid-19 vaccines to lower-income economies eligible for support over the next two years, it said on Friday.
The COVAX facility, run jointly with the World Health Organization, has delivered 90 million doses to 132 countries since February.
In a statement after its two-day board meeting it said that its goal of delivering 1.8 billion doses to lower income economies would be reached in the first quarter of 2022.
Keep updated, follow The Business Standard's Google news channel
